Our story
Cancercell metastasis is the leading cause of cancer patient death. Approximately 90%of cancer patient deaths are caused by cancer cell metastasis. However, mostclinical anti-cancer drugs are currently designed to inhibit the proliferationof cancer cells. There is a lack of drugs specifically designed to block cancercell metastasis, and there is no commercial high-throughput screening platformfor efficiently identifying novel anti-metastatic drugs either. Futureanti-tumor therapeutic strategies must adopt growth inhibitors, in combinationwith anti-metastasis drugs to treat advanced cancer patients, which willgreatly improve the curative rate of cancer and significantly prolong patients' survival time. At Exploring Health LLC, we have successfully developed ahigh-throughput screening platform that can rapidly and efficiently identifyanti-metastatic leading compounds. With our innovative high-throughputtechnology platform for screening anti-metastatic drugs, we are fully committedto developing anti-metastatic drugs to provide the medical industry with novelanti-cancer therapeutic strategies, which will revolutionize cancertherapeutics and significantly prolong patients' survival time.
Our mission
Enriching life by overcoming diseases.
Our vision
Developing drugs from multiple angles and safeguarding lives from different dimensions.
Our values
Accountability, Boldness, Cooperation, and Diversity.
Founder, CEO
Chief Technology Officer
Technical Consultant
Deputy General Manager